Pre-procedural patient assessment, symptomatic evaluation, and, if needed, POC ultrasound may help identify patients at risk of aspiration events
Aug 28 2020;12(9)doi:10.3390/nu12092631 Farshidi H, Sobhani AR, Eslami M, et al
The next wave dual and triple agonists (GLP-1 + GIP + glucagon: tirzepatide, retatrutide, survodutide) are showing superior fat loss, better hepatic outcomes, and potentially preserved lean mass
At En Vogue IV Therapy & Wellness in Southampton, PA, our mission is to help you achieve your health and wellness goals
Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial